TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2015

Clinical Utility of Metrics Based on Tumor Measurements in Phase II Trials to Predict Overall Survival Outcomes in Phase III Trials by Using Resampling Methods.

Ming-Wen An et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.